Toxicology effects of Berberis vulgaris (barberry) and its active constituent, berberine: a review
- PMID: 28656087
- PMCID: PMC5478780
- DOI: 10.22038/IJBMS.2017.8676
Toxicology effects of Berberis vulgaris (barberry) and its active constituent, berberine: a review
Abstract
Berberis vulgaris and berberine, its main component, traditionally have been used for treatment of various disorders. The pharmacological properties of them have been investigated using different in vivo and in vitro models. In spite of beneficial effects of B. vulgaris on different cell lines, there are documents have revealed negative impacts of it on animal and human. In this regards, the determination of its toxicity in a scientific view is necessary. In current report, we provide classified information about the toxicity of B. vulgaris and berberine in different conditions consist of acute, sub-acute, sub-chronic and chronic state. Besides, it discusses the cytotoxicity, genotoxicity, mutagenicity, and carcinogenicity of B. vulgaris and berberine as well as developmental toxicity and clinical studies. Data from the present study indicate that their toxicity is depending on the route and duration of administration. According to present study, they could induce GI upset and ulceration, immunotoxicity, phototoxicity, neurotoxicity, cardiotoxicity and jaundice in a dose dependent manner. They should be used with caution in pregnancy, neonatal and G6PD deficiency. Besides, consideration should be taken in co-administration of berberine with drugs that are metabolized with CYP enzymes due their inhibitory effects on these enzymes. Furthermore, they evoke cytotoxicity on both normal and cancer cell line which is time and concentration dependent.
Keywords: Acute toxicity; Berberine; Berberis vulgaris; CYP enzyme; Cancer cell; Chronic toxicity; Developmental toxicity; Pregnancy.
Figures




Similar articles
-
Berberine and barberry (Berberis vulgaris): A clinical review.Phytother Res. 2019 Mar;33(3):504-523. doi: 10.1002/ptr.6252. Epub 2019 Jan 13. Phytother Res. 2019. PMID: 30637820 Review.
-
Berberis Vulgaris and Berberine: An Update Review.Phytother Res. 2016 Nov;30(11):1745-1764. doi: 10.1002/ptr.5693. Epub 2016 Aug 16. Phytother Res. 2016. PMID: 27528198 Review.
-
Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine.Phytother Res. 2008 Aug;22(8):999-1012. doi: 10.1002/ptr.2399. Phytother Res. 2008. PMID: 18618524 Review.
-
Effects of Berberis vulgaris, and its active constituent berberine on cytochrome P450: a review.Naunyn Schmiedebergs Arch Pharmacol. 2025 Jan;398(1):179-202. doi: 10.1007/s00210-024-03326-x. Epub 2024 Aug 14. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 39141022 Review.
-
Anti-inflammatory, antioxidant, and immunomodulatory effects of Berberis vulgaris and its constituent berberine, experimental and clinical, a review.Phytother Res. 2024 Apr;38(4):1882-1902. doi: 10.1002/ptr.8077. Epub 2024 Feb 15. Phytother Res. 2024. PMID: 38358731 Review.
Cited by
-
Effect of Berberine against Cognitive Deficits in Rat Model of Thioacetamide-Induced Liver Cirrhosis and Hepatic Encephalopathy (Behavioral, Biochemical, Molecular and Histological Evaluations).Brain Sci. 2023 Jun 12;13(6):944. doi: 10.3390/brainsci13060944. Brain Sci. 2023. PMID: 37371422 Free PMC article.
-
Comparison of Sonodynamic Treatment Set-Ups for Cancer Cells with Organic Sonosensitizers and Nanosonosensitizers.Pharmaceutics. 2023 Nov 11;15(11):2616. doi: 10.3390/pharmaceutics15112616. Pharmaceutics. 2023. PMID: 38004594 Free PMC article.
-
Inorganic nanoparticles and natural dyes for production of antimicrobial and antioxidant wool fiber.3 Biotech. 2019 Dec;9(12):456. doi: 10.1007/s13205-019-1974-3. Epub 2019 Nov 19. 3 Biotech. 2019. PMID: 31832303 Free PMC article.
-
Daidzein and puerarin synergistically suppress gastric cancer proliferation via STAT3/FAK pathway Inhibition.Hereditas. 2025 Apr 11;162(1):58. doi: 10.1186/s41065-025-00419-2. Hereditas. 2025. PMID: 40217305 Free PMC article.
-
Antiarthritic activities of berberine in a rat model of gouty arthritis.Sci Rep. 2025 Sep 1;15(1):32153. doi: 10.1038/s41598-025-16622-0. Sci Rep. 2025. PMID: 40890319 Free PMC article.
References
-
- Rounsaville TJ, Ranney TG. Ploidy levels and genome sizes of Berberis L. and Mahonia Nutt. species, hybrids, and cultivars. HortScience. 2010;45:1029–1033.
-
- Bone K, Mills S. Materia medica. Principles and practice of phytotherapy modern herbal medicine. 2st ed. USA: Churchill livingstone; 2013. pp. 399–418.
-
- Ahrendt LWA. Berberis and Mahonia:a taxonomic revision. Bot J Linn Soc. 1961;57:1–410.
-
- Imanshahidi M, Hosseinzadeh H. Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. Phytother Res. 2008;22:999–1012. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous